2006
|
Invention
|
2-indolyl imidazo⏧4,5-d]phenanthroline derivatives and their use in the treatment of cancer.... |
|
Invention
|
Use of interleukin 17e for the treatment of cancer. The use of interleukin 17E to inhibit tumour ... |
2005
|
Invention
|
Combination preparation of a biological response modifier and an anticancer agent and uses thereo... |
|
Invention
|
Small interfering rna molecules against ribonucleotide reductase and uses thereof. Small interfer... |
|
Invention
|
Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combinatio... |
2004
|
Invention
|
Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatm... |
|
Invention
|
Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatm... |
2000
|
Invention
|
Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms.... |
|
Invention
|
Antisense oligonucleotide sequences derived from groel and groes as inhibitors microorganisms. Th... |
|
Invention
|
Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase. ... |
1999
|
Invention
|
Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to mo... |
|
Invention
|
Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth.... |
|
Invention
|
Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods... |
1998
|
Invention
|
Antisense oligonucleotide sequences as inhibitors of microorganisms. The invention relates to ant... |
|
Invention
|
Suppression of malignancy utilizing ribonucleotide reductase r1. The present invention provides a... |